Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Asset Utilization Ratio (2021 - 2025)

Inventiva (IVA) posted quarterly Asset Utilization Ratio of 0.0 for Q2 2021, up 5.44% quarter-over-quarter from 0.0 in Q1 2021.

Analysis

Inventiva (IVA) Asset Utilization Ratio (2021 - 2025) Analysis & Trends

Inventiva's Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q2 2021.

  • In Q2 2021, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2021 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.04, down 71.64% from the prior year.
  • Asset Utilization Ratio for Q2 2021 stood at 0.0, up from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.07 in Q4 2020, with the low at 0.0 in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -0.02
Jun 30, 2024 0.09
Jun 30, 2022 0.00
Jun 30, 2021 0.00